FDA Finalizes Adhesion Guidance for Transdermal Drug Systems

The FDA finalized guidance on assessing the adhesion performance of transdermal and topical drug delivery systems for generic applications. This updated document replaces a previous draft, aiming to ensure the quality and efficacy of generic TDS products, impacting pharmaceutical manufacturers and patient safety.